Search results for "CD28"

showing 10 items of 70 documents

MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculo…

2007

Novel diagnostic tools are needed to diagnose latent infection and to provide biologically meaningful surrogate markers to define cellular immune responses against Mycobacterium tuberculosis (MTB). Interferon gamma-based assays have recently been developed in addition to the more than 100-year-old tuberculin skin test (TST) for the immune diagnosis of MTB in blood. The advent of soluble MHC/peptide tetramer molecules allows to objectively enumerate antigen-specific T cells. We identified novel MHC class II-restricted MTB epitopes and used HLA-DR4 tetrameric complexes to visualize ex vivo CD4(+) T cells directed against the antigens Ag85B and the 19-kDa lipoprotein, shared between MTB and ot…

CD4-Positive T-LymphocytesImmunologyMolecular Sequence DataEpitopes T-Lymphocytechemical and pharmacologic phenomenaMajor histocompatibility complexEpitopeImmune systemAntigenMHC class IHumansAmino Acid SequenceTuberculosis PulmonaryMHC class IIAntigen PresentationAntigens BacterialbiologyHistocompatibility Antigens Class IICD28General MedicineMycobacterium tuberculosisrespiratory systembacterial infections and mycosesVirologyImmunologybiology.proteinCD8Scandinavian journal of immunology
researchProduct

CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.

2002

Interleukin-10 (IL-10)–treated dendritic cells (DCs) induce an alloantigen- or peptide-specific anergy in various CD4+ and CD8+ T-cell populations. In the present study, we analyzed whether these anergic T cells are able to regulate antigen-specific immunity. Coculture experiments revealed that alloantigen-specific anergic CD4+ and CD8+ T cells suppressed proliferation of syngeneic T cells in a dose-dependent manner. The same effect was observed when the hemagglutinin-specific CD4+T-cell clone HA1.7 or tyrosinase-specific CD8+ T cells were cocultured with anergic T cells of the same specificity. Anergic T cells did not induce an antigen-independent bystander inhibition. Suppression was depe…

CD4-Positive T-LymphocytesIsoantigensImmunoconjugatesImmunologyAntigen-Presenting Cellschemical and pharmacologic phenomenaBiologyCD8-Positive T-LymphocytesLymphocyte ActivationBiochemistryT-Lymphocytes RegulatoryAbataceptInterleukin 21Antigens CDAntigens NeoplasmCytotoxic T cellHumansCTLA-4 AntigenIL-2 receptorLeukapheresisAntigen-presenting cellMelanomaCells CulturedClonal AnergyImmunosuppression TherapyMonophenol MonooxygenaseCD28Cell BiologyHematologyDendritic cellT lymphocyteDendritic CellsNatural killer T cellAntigens DifferentiationCoculture TechniquesCell biologyInterleukin-10ImmunologyCD4 AntigensLeukocytes MononuclearCell DivisionBlood
researchProduct

Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.

2005

CD8+ T cells have a crucial role in resistance to pathogens and can kill malignant cells; however, some critical functions of these lymphocytes depend on helper activity provided by a distinct population of CD4+ T cells. Cooperation between these lymphocyte subsets involves recognition of antigens co-presented by the same dendritic cell, but the frequencies of such antigen-bearing cells early in an infection and of the relevant naive T cells are both low. This suggests that an active mechanism facilitates the necessary cell-cell associations. Here we demonstrate that after immunization but before antigen recognition, naive CD8+ T cells in immunogen-draining lymph nodes upregulate the chemok…

CD4-Positive T-LymphocytesReceptors CCR5T cellAntigen presentationCell CommunicationBiologyCD8-Positive T-LymphocytesLymphocyte ActivationInterleukin 21MiceCell MovementmedicineCell AdhesionCytotoxic T cellAnimalsAntigen-presenting cellChemokine CCL4Chemokine CCL3MultidisciplinaryCD28Dendritic cellDendritic CellsMacrophage Inflammatory ProteinsNatural killer T cellmedicine.anatomical_structureChemokines CCImmunologyLymph NodesChemokinesImmunologic MemoryNature
researchProduct

Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with me…

2011

Background HLA mismatch antigens are major targets of alloreactive T cells in HLA-incompatible stem-cell transplantation, which can trigger severe graft- versus -host disease and reduce survival in transplant recipients. Our objective was to identify T-cell subsets with reduced in vitro reactivity to allogeneic HLA antigens. Design and Methods We sorted CD4 and CD8 T-cell subsets from peripheral blood by flow cytometry according to their expression of naive and memory markers CD45RA, CD45RO, CD62L, and CCR7. Subsets were defined by a single marker to facilitate future establishment of a clinical-grade procedure for reducing alloreactive T-cell precursors and graft- versus -host disease. T c…

CD4-Positive T-LymphocytesReceptors CCR7LymphocyteT-LymphocytesGraft vs Host DiseaseHuman leukocyte antigenBiologyCD8-Positive T-LymphocytesInterleukin 21AntigenHLA AntigensCell Line TumormedicineCytotoxic T cellHumansTransplantation HomologousPrecursor Cells T-LymphoidLeukemiaCD28HematologyT lymphocyteOriginal ArticlesTissue Donorsmedicine.anatomical_structureImmunologyImmunotherapyK562 CellsImmunologic MemoryCD8Haematologica
researchProduct

Microenvironment Regulation of IL23R/IL-23 Axis Drives Chronic Lymphocytic Leukemia (CLL) Progression

2015

Abstract Background : CLL displays a considerable degree of clinical heterogeneity, which is in part ascribable to clone-intrinsic biological features and that are also influenced by clone-extrinsic events related to the microenvironment. Among the dynamics-taking place within the CLL microenvironment, those finalized to the induction of an overly inflammatory milieu may significantly impact on the CLL natural history by hijacking the immunological microenvironment at the same time fostering clone fitness. IL-23 acts as a prototypical pro-inflammatory mediator representing a promising therapeutic target. We analyzed the ability of CLL cells to sense IL-23 through the IL-23R complex (consist…

CD40biologymedicine.diagnostic_testChronic lymphocytic leukemiaImmunologyClone (cell biology)CD28Cell BiologyHematologymedicine.diseaseBiochemistryCD19Flow cytometryLymphocyte costimulationbiology.proteinmedicineCancer researchCD5Blood
researchProduct

In Naive mice in vivo localization of WI specific CD8+CD28- induced cells

2008

CD8+CD28-Settore BIO/17 - IstologiaSettore MED/04 - Patologia Generale
researchProduct

B7-1 and B7-2 act differentially in the induction of a T cell response: their impact for a HLA-matched and HLA-mismatched anti-tumor immunotherapy.

2005

The efficacy of T cell-based immunotherapy is primarily due to efficient cellular activation that requires the engagement of 2 separate signals, i.e., via the T cell receptor complex and via co-stimulatory molecules the prototype of which is CD28. In cellular activation, the CD28 ligands B7-1 (CD80) and B7-2 (CD86) are thought to play nearly identical roles in T cell activation. We monitored the T cell response upon co-culture with HLA Class I-matched and mismatched renal carcinoma cells, respectively, that express different levels of B7-1 and B7-2, respectively. In a HLA Class I-mismatched co-culture, T cell proliferation, IFN-γ and GM-CSF secretion equally depend on the levels of B7-1 and…

CD86Cancer Researchmedicine.medical_treatmentT cellT-LymphocytesCD28ImmunotherapyHuman leukocyte antigenStreptamerBiologyKidney Neoplasmsmedicine.anatomical_structureOncologyHLA AntigensCell Line TumorImmunologymedicineB7-1 AntigenCytotoxic T cellHumansB7-2 AntigenImmunotherapyLymphocyte Culture Test MixedCarcinoma Renal CellCD80International journal of cancer
researchProduct

ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells

2002

With newly generated ICOS-ligand (ICOS-L)-specific monoclonal antibodies we determined that human Langerhans cells in situ express similar levels of ICOS-L, CD80, and CD86, compared to immature dendritic cells (DC) derived from monocytes in vitro. Maturation of DC strongly up-regulated CD80 and CD86 but did not significantly change ICOS-L levels. On coculture of "naive"CD4(+) T cells with mature DC in the presence of superantigen, ICOS was highly up-regulated on T cells, but played only a secondary role in the CD28-dominated release of TNF-alpha and IFN-gamma, and did not participate in the induction of IL-2. Cocultures of "effector" CD4(+) T cells with mature DC revealed CD28 as the drivin…

CD86EffectorImmunologyCD28chemical and pharmacologic phenomenahemic and immune systemsBiologyCell biologyICOS LIGANDInterleukin 10CTLA-4Immunology and AllergySecretionCD80European Journal of Immunology
researchProduct

2004

Cancer ResearchInterleukin 21OncologyChemistryZAP70GeneticsCD28Cytotoxic T cellIL-2 receptorNatural killer T cellAntigen-presenting cellJurkat cellsCell biologyCancer Cell International
researchProduct

Elevated NKG2D ligand expression in experimental autoimmune encephalomyelitis

2014

T cells remain unclear. Expressing myelin-reactive T cell receptor (TCR) is not sufficient to make a T cell encephalitogenic. In fact, the frequencies of myelin-reactive T cells are comparable between MS patients and healthy individuals, but the ones in MS patients have activated/memory phenotypes. In the animal model of MS, experimental autoimmune encephalomyelitis (EAE), myelin-specific T cells activated with antigen presenting cells (APCs) plus myelin peptide are encephalitogenic, whereas T cells activated with anti-CD3/CD28 antibodies are not. This suggests that APCs provide critical cytokines beyond T cell receptor activation and co-stimulation, contributing to encephalitogenicity. To …

Chemistrymedicine.medical_treatmentT cellImmunologyT-cell receptorExperimental autoimmune encephalomyelitisCD28T-Cell Receptor Activationmedicine.diseaseCytokinemedicine.anatomical_structureNeurologyImmunologymedicineImmunology and AllergyNeurology (clinical)Antigen-presenting cellReceptorJournal of Neuroimmunology
researchProduct